Report cover image

Global 3D Printed Drugs Market Size, Trends & Growth Opportunity, By Technology, By End-Use, By Application, By Region and Forecast Till 2027.

Publisher QualiKet Research
Published Dec 01, 2022
SKU # QUA17624091

Description

Global 3D Printed Drugs Market Size, Trends & Growth Opportunity, By Technology, By End-Use, By Application, By Region and forecast till 2027.

Global 3D Printed Drugs Market

Global 3D Printed Drugs Market was valued at $291.82 million in 2021 and is predicted to reach up to $458.52 million by 2027 at a CAGR of 7.8% from 2022-2027.

Custom-made prosthetics, implants, and other medical items are being produced using 3D printing technology more frequently in the medical sector. Even 3D bio-printed organs are being created using 3D printing technology. Pharmacy technicians and medical engineers can now edit a drug's design directly in its CAD file thanks to technology used in the pharmaceutical sector. Additionally, it enables the healthcare provider to print medications as needed rather than in bulk.

Prescriptions for safe and effective custom pharmaceuticals are made utilising the 3D printing method and are known as 3D printed drugs. These drugs don't require swallowing huge doses whole since they have a unitary porous architecture that disperses quickly in the mouth. It makes it simple for manufacturers to change a variety of medications' size, shape, appearance, form, and rate of distribution. Patients who frequently struggle with swallowing, kids, seniors, those living with stroke, Alzheimer's disease, head and neck cancers, and other neurological problems can all benefit from this type of drug.

Market Drivers

The primary driver of the growth of the global 3D printed medicines market is the surge in demand for instantly soluble drugs that can disperse readily in the mouth. Additionally, the rise in the prevalence of dysphagia, the use of 3D printing in the medical and healthcare sectors, the adoption of personalised medicines, and the creation of combination medicines all contribute to the market's expansion. The industry is flourishing because to the increased demand for personalised medications and the quickly expanding R&D activities that support 3D printing.

Pharmaceuticals created via 3D printing are gaining popularity since they are simple to consume and practically instantly dissolve. Personalized treatments can better support patients than batch-produced medications since they can be tailored to each patient's unique needs. As a result, it is anticipated that the market for these medications would grow during the forecast period.

Market Restraints

The market's expansion is constrained by negative drug-related side effects, the use of 3D printing to create illicit pharmaceuticals, and a lack of government restrictions for 3D printed goods.

Impact of COVID-19

The use of 3D printing has increased as a result of the COVID-19 outbreak. To help with the creation of medicines and other necessary products, the operational actors in the advanced manufacturing industry have introduced a number of 3D printers. Additionally, the COVID-19 pandemic's drug shortage has raised pharmaceutical companies' attention to the idea of using 3D printing technology to supply medications quickly.

Market Segmentation

The Global 3D Printed Drugs Market is segmented into Technology, End-Use, Application. By Technology such as Inkjet Printing, Fused Deposition Modeling, Stereolithography, ZipDose

Technology. By End-Use such as Hospitals & clinics, Research Laboratories, Others. By Application such as Orthopedic, Neurology, Dental, Hearing & Audibility Aid, Others.

Regional Analysis

The Global 3D Printed Drugs Market is segmented into five regions North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. With a share of 37.23% in the regional market in 2021, North America held the majority of the market. The high prevalence of chronic diseases, the superior domestic healthcare infrastructure, the significant investment in R&D, and the rising adoption of technology advancements in the North American region are all factors that contribute to this significant proportion. Due to considerable advancements made by China and Japan in the technological application of 3D printed medication techniques, the Asia Pacific is predicted to have the quickest growth rate. Additionally, the expansion of clinical development frameworks, R&D, and healthcare infrastructure in rising nations like Australia and India has positioned the Asia Pacific market to see profitable prospects and growth over the course of the projection period.

Kay Players

This report includes a list of numerous Key Players, namely Aprecia, Extend Biosciences, Bioduro, Affinity Therapeutics, Osmotica Pharmaceuticals, Aprecia Pharmaceuticals LLC, GlaxoSmithKline Plc, FabRx Ltd, Hewlett Packard Caribe, Merck.

Market Taxonomy

By Technology
  • Inkjet Printing
  • Fused Deposition Modeling
  • Stereolithography
  • ZipDose Technology.
By End-Use
  • Hospitals & clinics
  • Research Laboratories
  • Others
By Application
  • Orthopedic
  • Neurology
  • Dental
  • Hearing & Audibility Aid
  • Others
By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Table of Contents

1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global 3D Printed Drugs Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global 3D Printed Drugs Market, By Technology
5.1 Y-o-Y Growth Comparison, By Technology
5.2 Global 3D Printed Drugs Market Share Analysis, By Technology
5.3 Global 3D Printed Drugs Market Size and Forecast, By Technology
5.3.1 Inkjet Printing
5.3.2 Fused Deposition Modeling
5.3.3 Stereolithography
5.3.4 ZipDose Technology.
6 Global 3D Printed Drugs Market, By End-use
6.1 Y-o-Y Growth Comparison, By End-use
6.2 Global 3D Printed Drugs Market Share Analysis, By End-use
6.3 Global 3D Printed Drugs Market Size and Forecast, By End-use
6.3.1 Hospitals & clinics
6.3.2 Research Laboratories
6.3.3 Others
7 Global 3D Printed Drugs Market, By Application
7.1 Y-o-Y Growth Comparison, By Application
7.2 Global 3D Printed Drugs Market Share Analysis, By Application
7.3 Global 3D Printed Drugs Market Size and Forecast, By Application
7.3.1 Orthopedic
7.3.2 Neurology
7.3.3 Dental
7.3.4 Hearing & Audibility Aid
7.3.5 Others
8 Global 3D Printed Drugs Market, By Region
8.1 Global 3D Printed Drugs Market Share Analysis, By Region
8.2 Global 3D Printed Drugs Market Share Analysis, By Region
8.3 Global 3D Printed Drugs Market Size and Forecast, By Region
9 North America 3D Printed Drugs Market Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 North America 3D Printed Drugs Market Share Analysis, By Technology
9.3 North America 3D Printed Drugs Market Size and Forecast, By End-Use
9.4 North America 3D Printed Drugs Market Size and Forecast, By Application
9.5 North America 3D Printed Drugs Market Size and Forecast, By Country
9.5.1 U.S.
10.5.2 Canada
10.5.3 Mexico
10 Europe 3D Printed Drugs Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Europe 3D Printed Drugs Market Share Analysis, By Technology
10.3 Europe 3D Printed Drugs Market Size and Forecast, By End-Use
10.4 Europe 3D Printed Drugs Market Size and Forecast, By Application
10.5 Europe 3D Printed Drugs Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4. Rest of Europe
11 Asia Pacific 3D Printed Drugs Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Asia Pacific 3D Printed Drugs Market Share Analysis, By Technology
11.3 Asia Pacific 3D Printed Drugs Market Size and Forecast, By End-Use
11.4 Asia Pacific 3D Printed Drugs Market Size and Forecast, By Application
11.5 Asia Pacific 3D Printed Drugs Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
13 Latin America 3D Printed Drugs Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Latin America 3D Printed Drugs Market Share Analysis, By Technology
13.3 Latin America 3D Printed Drugs Market Size and Forecast, By Application
13.4 Latin America 3D Printed Drugs Market Size and Forecast, By End-use
13.5 Latin America 3D Printed Drugs Market Size and Forecast, Country
13.5.1. Brazil
13.5.2. Rest of Latin America
14 Middle East 3D Printed Drugs Market Analysis and Forecast (2022-2027)
14.1 Introduction
14.2 Middle East 3D Printed Drugs Market Share Analysis, By Technology
14.3 Middle East 3D Printed Drugs Market Size and Forecast, By End-Use
14.4 Middle East 3D Printed Drugs Market Size and Forecast, By Application
14.5 Middle East 3D Printed Drugs Market Size and Forecast, By Country
14.5.1. Saudi Arabia
14.5.2. UAE
14.5.3. Egypt
14.5.4. Kuwait
14.5.5. South Africa
15 Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16 Company Profiles
16.1 Aprecia
16.1.1 Overview
16.1.2 Products
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 Extend Biosciences
16.2.1 Overview
16.2.2 Products
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3 Bioduro
16.3.1 Overview
16.3.2 Products
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 Affinity Therapeutics
16.4.1 Overview
16.4.2 Products
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 Osmotica Pharmaceuticals
16.5.1 Overview
16.5.2 Products
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 Aprecia Pharmaceuticals LLC
16.6.1 Overview
16.6.2 Products
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 GlaxoSmithKline Plc
16.7.1 Overview
16.7.2 Products
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
16.8 FabRx Ltd
16.8.1 Overview
16.8.2 Products
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9 Hewlett Packard Caribe
16.9.1 Overview
16.9.2 Products
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies
16.10 Merck
16.10.1 Overview
16.10.2 Products
16.10.3 Key Financials
16.10.4 Business Segment & Geographic Overview
16.10.5 Key Market Developments
16.10.6 Key Strategies

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us